New KRAS-Targeting Cancer Vaccine Safe, Immunogenic in Trials
Memorial Sloan Kettering Cancer Center
Off-the-shelf vaccines are as efficacious as mRNA vaccines and are cheaper to produce and administer
mRNA
Overlapping Epitopes to Develop Safe, Better-Suited Vaccines
Heinrich Heine University Düsseldorf
Epitopes are an alternative to mRNA and may elicit targeted immune responses quickly, cost-effectively, and safely
Realizing the Promise of mRNA Tech to Revolutionize Global Health
Drew Burch, MBA
Biopharmaceutical perspective on how the past, present, and future of mRNA technology will impact health care
Novel Method Uses Sebum to Diagnose Infant Atopic Dermatitis
Kao Corporation
A breakthrough RNA-monitoring method enables early detection of early-onset atopic dermatitis using sebum biomarkers
Overcoming mRNA Process Challenges
Scott Ripley
For mRNA technology to reach its full potential, innovations in manufacturing are needed
COVID-19 mRNA Vaccines Greatly Reduce Risk of Asymptomatic Infection
Mayo Clinic
Two doses of mRNA COVID-19 vaccine led to 80 percent risk reduction of testing positive for COVID-19
COVID-19 and Sepsis: Risk-Stratifying Patients Based on Their Immune Response
Timothy E. Sweeney, MD, PhD
Host-response diagnostics that “read” the immune response can help clinicians make better, faster treatment decisions
How COVID-19 mRNA Vaccines Work
Amanda Maxwell, PhD
mRNA vaccines employ a novel strategy to stimulate immunity against coronavirus spike proteins